Literature DB >> 25739103

Understand, elucidate and rationalize the coordination mode of pyrimidylmethylamines: an intertwined study combining NMR and DFT methods.

J E Herbert Pucheta1, M Candy, O Colin, A Requet, F Bourdreux, E Galmiche-Loire, A Gaucher, C Thomassigny, D Prim, M Mahfoudh, E Leclerc, J-M Campagne, J Farjon.   

Abstract

Conception of new pyrimidylmethylamine (pyrma) ligands and their corresponding Pd(II) complexes has been described. Both symmetrical and non-symmetrical ligands were prepared and subjected to complexation. Two different coordination modes, Pd(N,N)- or Pd(C,N,N)-pyrma, have been evidenced depending on the substitution of the pyrimidine ring and the nature or the shape of the additional pendant arm. In a non-symmetrical pyrimidine series, the substituent-induced discrimination of each heterocyclic nitrogen atom provoked regio-controlled coordination to the metal center. The molecular structure of pyrma-Pd(II) complexes in the solution state has been elucidated thanks to combined NMR experiments and DFT calculations. This study highlights the potency of (15)N and (13)C NMR spectroscopy for the elucidation of the regio-selective coordination to the Pd(II) in the pyrma-based complex series. DFT calculations were highly relevant to the identification of crucial factors that govern the regio-selectivity and the complexation modes. Close predicted and experimental chemical shift values put into relief the reliability of coordination modes for the most stable complexes in solution, depicted by DFT approaches.

Entities:  

Year:  2015        PMID: 25739103     DOI: 10.1039/c5cp00241a

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  1 in total

1.  Straightforward synthesis of various chiral pyrimidines bearing a stereogenic center adjacent to the C-2 position, including C-terminal peptide isosteres.

Authors:  Sami Sahtel; Chayma Ben Maamer; Rafâa Besbes; Emmanuel Vrancken; Jean-Marc Campagne
Journal:  Amino Acids       Date:  2022-10-13       Impact factor: 3.789

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.